23and me stock.

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 0.90. The median ...23andMe Reports FY2022 Third Quarter Financial Results. 1. 23andMe, Inc. February 10, 2022 at 4:04 PM · 22 min read. Third quarter revenue of $57 million. Therapeutics group advances first wholly ...See the latest 23andMe Holding Co Class A stock price (ME:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The deal valued 23andMe's outstanding shares of capital stock at $3.5 billion. The vast majority of shareholders of VG Acquisition Corp., which was founded by Virgin Galactic's Richard Branson, ...Research 23andMe Holding's (Nasdaq:ME) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener 23andMe Holding Co.

Nov 28, 2023 · 27.2%. -28.6%. Market Cap. The market value of a company, in total dollars, also called "market capitalization." Market cap is calculated by taking a company's price per share and multiplying it ... The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.1 de mai. de 2023 ... ... #youtube #yahoofinance 23andMe CEO Anne Wojcicki joins Yahoo Finance Live's Brian Sozzi from the ... stock quotes, up-to-date news, portfolio ...

This price target is based on 2 analysts offering 12 month price targets for 23andMe in the last 3 months. The average price target is $4.38, with a high forecast of $7.00 and a low forecast of $1.75. The average price target represents a 370.58% upside from the last price of …1w 1m 6m ytd 1y 3y 5y max Mountain-Chart Compare with Compare with up to 5 Stocks On Friday morning 11/24/2023 the 23andMe Holding Co Registered Shs -A- share started …

Jun 9, 2021 · Meanwhile, at VGAC’s current stock price, 23andMe is valued at around $4.56 billion. After adjusting for its pro forma $984 million net cash, it would have an EV (enterprise value) of $3.58 ... Oct 17, 2021 · In June, 23andMe ( ME 2.88%) officially finished the process of going public via a special purpose acquisition company ( SPAC ). These investment vehicles were popular in early 2021, but many have ... 23andMe, the consumer genetics company that popularized at home DNA test kits, is going public via merger with a SPAC. The company will merge with Richard Branson's VG Acquisition Corp. in a deal ... 23andMe saw a increase in short interest in October. As of October 31st, there was short interest totaling 26,900,000 shares, an increase of 0.4% from the previous total of 26,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price ...By Bret Kenwell, InvestorPlace Contributor Aug 11, 2022, 3:12 pm EST. 23andMe ( ME) stock has more than doubled so far this month, with shares up 127% at today’s high from the July 29 low ...

Nov 27, 2023 · 2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price.

Join our diverse team of ever-curious scientists, engineers, researchers, marketers and many more who share one common goal–to make a difference in people’s lives. 23andMe is a genetics and health company that believes you should be able to access, understand and benefit from all the endlessly interesting things your DNA can tell you.

Oct 22, 2021 · Shares of 23andMe Holding ( ME 2.88%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ... ME. +6.60%. Shares of 23andMe Holding Co. ME rallied more than 12% in the extended session Wednesday after the genetics company raised guidance for 2023. 23andMe lost $92 million, or 20 cents a ...Nov 8, 2023 · SOUTH SAN FRANCISCO, Calif. (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the second quarter of ... 23andMe Holding Co. Class A Common Stock (ME) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of 23andMe Holding ( ME 3.64%) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and ...23andMe price target lowered to $3 from $5 at TD Cowen November 9, 2023TipRanks. Analysts Conflicted on These Healthcare Names: Sana Biotechnology (SANA), 23andMe Holding (ME) and Invitae (NVTA ...Key Data. Open $0.9108. Day Range 0.8750 - 0.9169. 52 Week Range 0.6101 - 3.4800. Market Cap $429.09M. Shares Outstanding 311.61M. Public Float 274.92M. Beta 1.77. Rev. per Employee $331.10K.

23andMe Holding Co. is the leading direct-to-consumer genetic testing company entering drug development with data on 11.3M Genotyped Customers and +$696M in SPAC funding.23andMe Holding Co. Class A Common Stock (ME) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Transaction will provide the capital to fund additional investment in key growth initiatives across 23andMe’s consumer health and therapeutics businesses; The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billionThe average price point forecasted by analysts for 23andMe Holding Co (ME) is $3.30, which is $2.44 above the current market price. The public float for ME is 269.01M, and currently, short sellers hold a 10.00% ratio of that floaft. The average trading volume of ME on November 21, 2023 was 3.42M shares. ME) stock’s […]r/MEstock: Welcome to this forum of 23&me for independent investors. 23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1

The Wall Street analyst predicted that 23andme Holding Co's share price could reach $1.75 by Aug 10, 2024. The average 23andme Holding Co stock price prediction ...23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.

23andMe Holding Co. analyst ratings, historical stock prices, earnings estimates & actuals. ME updated stock price target summary.23andMe is known for its ancestry DNA genetic testing service, but the company faces disruption from whole genome sequencing. Read why I rate ME stock a sell.Find the latest 23andMe Holding Co. (ME) stock quote, history, news and other vital information to help you with your stock trading and investing.Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.How to buy 23andMe stock Currently, the SPAC is listed as "VGAC" on the NYSE. After the IPO, retail investors will be able to buy shares of 23andMe through the new ticker symbol "ME."Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating. May. 26. MT. Berenberg Bank Initiates Coverage on 23andMe Holding With Buy Rating, $7 Price Target. Nov. 29. MT. Credit Suisse Trims 23andMe Holding's Price Target to $6 From $7, Keeps Outperform Rating. Nov. 08. MT.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 0.90. The median ...1 de mai. de 2023 ... ... #youtube #yahoofinance 23andMe CEO Anne Wojcicki joins Yahoo Finance Live's Brian Sozzi from the ... stock quotes, up-to-date news, portfolio ...10 de jun. de 2021 ... The implied equity value of $3.6 billion includes the value of the options exercisable for shares of New 23andMe Class A Common Stock that are ...

23andMe Holding Third Quarter 2023 ResultsKey Financial Results. Revenue: US$66.9m (up 18% from 3Q 2022). Net loss: US$92.0m (loss widened by 2.9% from 3Q 2022). US$0.20 loss per share.

4 de ago. de 2021 ... 23andMe completes merger with Richard Branson's VG Acquisition Corp. and is now trading stock on NASDAQ.

FY2023 Financial Guidance. 23andMe is raising its full year guidance following Q3 FY2023 results. Full year revenue for fiscal year 2023, which will end on March 31, 2023, is projected to be in the range of $290 to $300 million, with a net loss in the range of $325 to $335 million. The full year Adjusted EBITDA deficit is projected to be in the ...ME stock looks attractively valued. 23andMe has an EV (enterprise value) of around $4.2 billion and is expected to generate revenues of $400 million in 2024, which would mean a 2024 EV-to-sales ...What happened. The stock market was experiencing a frothy Friday on the last trading day of the week, but 23andMe Holding (ME 1.82%) was a bit of a wallflower at the party. As of 1:30 p.m. ET ...All Those 23andMe Spit Tests Were Part of a Bigger Plan. CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone ...That includes oncology, respiratory, and cardiovascular diseases. Trading for ME stock is starting off heavy today with some 1.1 million shares trading hands. That’s approaching its average ...ME Earnings Date and Information. 23andMe last announced its earnings results on November 8th, 2023. The reported ($0.16) EPS for the quarter. The company had revenue of $50 million for the quarter, compared to analyst estimates of $56.80 million. 23andMe has generated ($0.73) earnings per share over the last year ( ($0.73) diluted …Find out all the key statistics for 23andMe Holding Co. (ME), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History ...Why 23andMe Holding Stock Plummeted by 13% Today. ME | Complete 23andMe Holding Co. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …6 de jul. de 2022 ... Hear how 23andMe was able to migrate their entire research workload into AWS with no operational disruption, thanks to the WEKA data ...Funding. 23andMe has raised a total of. $1.1B. in funding over 19 rounds. Their latest funding was raised on Jun 17, 2021 from a Post-IPO Equity round. 23andMe is registered under the ticker NASDAQ:ME . 23andMe is funded by 39 investors. Richard Branson and Altimeter Capital are the most recent investors. 23andMe has a post-money valuation in ...

Jun 24, 2021 · In 2019, the company brought in $441 million in revenue, with consumer services accounting for 96% of sales. However, its forecast for this year amounts to just $243.5 million in sales. 23andMe is ... 10 de jun. de 2021 ... The implied equity value of $3.6 billion includes the value of the options exercisable for shares of New 23andMe Class A Common Stock that are ...SUNNYVALE, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, today announced that it has completed its ...Instagram:https://instagram. health insurance companies for young adultsstocks under dollar5 that will explodebank of new york mellon stock pricebest places to sell iphone ME. +10.27%. DNA-testing company 23andMe confirmed Monday that information about 6.9 million people, about half of its 14 million customers, was accessed … best option advisory servicesnoop dogg ice cube concert Shares of genetic data miner 23andMe Holding ( ME -2.24%) had surged 16% as of 12:15 p.m. EDT trading Friday after the stock received a positive mention on CNBC last night. top 100 wealth management firms (ME) Cotação da empresa 23andMe com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ.23andMe Reports FY2022 Third Quarter Financial Results. 1. 23andMe, Inc. February 10, 2022 at 4:04 PM · 22 min read. Third quarter revenue of $57 million. Therapeutics group advances first wholly ...